✦ LIBER ✦

Highly Selective and Potent Agonists of Sphingosine-1-phosphate 1 (S1P1) Receptor.

✍ Scribed by Petr Vachal; et al. et al.

Publisher: John Wiley and Sons
Year: 2006
Weight: 11 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200640128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis of Benzimidazole Based Analogu

Synthesis of Benzimidazole Based Analogues of Sphingosine-1-phosphate: Discovery of Potent, Subtype-Selective S1P4 Receptor Agonists.

✍ Jeremy J. Clemens; Michael D. Davis; Kevin R. Lynch; Timothy L. Macdonald 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 168 KB 👁 1 views

Discovery of 3-Arylpropionic Acids as Po

Discovery of 3-Arylpropionic Acids as Potent Agonists of Sphingosine-1-phosphate Receptor-1 (S1P1) with High Selectivity Against All Other Known S1P Receptor Subtypes.

✍ Lin Yan; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 14 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

ChemInform Abstract: Exploration of Amin

ChemInform Abstract: Exploration of Amino Alcohol Derivatives as Novel, Potent, and Highly Selective Sphingosine-1-phosphate Receptor Subtype-1 Agonists.

✍ Ghotas Evindar; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

2,5-Disubstituted Pyrrolidine Carboxylat

2,5-Disubstituted Pyrrolidine Carboxylates as Potent, Orally Active Sphingosine-1-phosphate (S1P) Receptor Agonists.

✍ Vincent J. Colandrea; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

2-Aryl(pyrrolidin-4-yl)acetic Acids are

2-Aryl(pyrrolidin-4-yl)acetic Acids are Potent Agonists of Sphingosine-1-phosphate (S1P) Receptors.

✍ Lin Yan; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

Synthesis of para-Alkyl Aryl Amide Analo

Synthesis of para-Alkyl Aryl Amide Analogues of Sphingosine-1-phosphate: Discovery of Potent S1P Receptor Agonists.

✍ Jeremy J. Clemens; Michael D. Davis; Kevin R. Lynch; Timothy L. Macdonald 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 133 KB